Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2014-11-18 Capital/Financing Update
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Divestment of Australian heritage business completed 2 pages 126.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 19 November 2014 about the completion of the sale of a business segment (Australian heritage business) by Genetic Technologies Limited. It discusses the divestment transaction details, strategic focus shift, and includes contact information and safe harbor statements. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a corporate announcement about a divestment transaction, which fits best under Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes. The document length is about 4923 characters, which is sufficient for a full announcement rather than a brief note. Therefore, the classification is CAP with high confidence.
2014-11-18 English
Nasdaq Notice 2 pages 127.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 6 November 2014 from Genetic Technologies Limited regarding a Nasdaq notice about non-compliance with Nasdaq listing rules due to insufficient stockholders' equity as reported in the company's Form 20-F for the fiscal year ended June 30, 2014. The announcement explains the Nasdaq deficiency notice and the company's required response timeline. The document is short (4050 characters) and primarily serves as a regulatory announcement about listing compliance status rather than containing financial statements or detailed report data. It references the Form 20-F but does not include the report itself. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about compliance and listing status, not a full financial report or earnings release.
2014-11-05 English
Appendix 3B 11 pages 467.3KB
Regulatory Filings
2014-10-30 English
US Annual Report on Form 20-F 149 pages 1.2MB
Annual Report Classification · 100% confidence The document is titled 'US Annual Report on Form 20-F' and is filed with the US Securities and Exchange Commission for the fiscal year ended June 30, 2014. It contains detailed sections typical of an annual report, including financial statements, management information, risk factors, and corporate governance. The length of the document (15,000 characters) and the presence of comprehensive financial and operational data confirm it is the full annual report, not just an announcement or summary. The Form 20-F is the SEC's annual report form for foreign private issuers, equivalent to a 10-K filing. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2014
2014-10-29 English
Quarterly Reports - September 30 2014 12 pages 4.7MB
Regulatory Filings
2014-10-27 English
Notice of 2014 AGM, Sample Proxy and Annual Report 145 pages 6.2MB
Report Publication Announcement Classification · 95% confidence The document is an ASX announcement dated 27 October 2014, titled 'Notice of 2014 Annual General Meeting, Sample Proxy and 2014 Annual Report.' It includes details about the upcoming AGM, the mailing of the Notice and proxy to shareholders, and mentions that the 2014 Annual Report is available for download from the company's website. The document contains the Notice of Meeting with agenda items such as consideration of financial statements, adoption of the remuneration report, and election of directors. The document is about the announcement and provision of materials related to the AGM, including the proxy and the annual report, but does not contain the full annual report itself. The text is approximately 15,000 characters, but the content is primarily an announcement and notice rather than the full report. According to the 'Menu vs Meal' rule, since the document states the Annual Report is available for download and the Notice and proxy will be mailed, this is an announcement of the report and meeting materials, not the report itself. Therefore, the correct classification is Report Publication Announcement (RPA).
2014-10-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.